Category: News

Mar 5, 2020

EPA Plans to Provide Additional Clarification on Self-Identifying as a Manufacturer or Importer of a High-Priority Chemical – Update from Bergeson & Campbell, P.C.

Given the considerable industry stakeholder confusion and angst that has arisen related to the January 27, 2020, U.S. Environmental Protection Agency (EPA) Federal Register notice on identifying the preliminary lists of manufacturers (including importers) of the 20 chemical substances that EPA designated as high-priority substances for risk evaluation and for which fees will […]

Mar 3, 2020

D.C. Circuit Follows Trend on Non-CERCLA Settlements That Leaves Guam Footing $160M CERCLA Bill – Update from Manko Gold

March 3, 2020 Austin W. Manning MGKF Litigation Blog Last month, the D.C. Circuit, reversing a lower court decision, held that Guam was time-barred from pursuing its claims under CERCLA against the US Navy for the cleanup of the Ordot Dump on the island. Government of Guam v. United States of […]

Mar 3, 2020

The Essential Value of Forming TSCA Consortia – Update from Bergeson & Campbell, P.C.

The Essential Value of Forming TSCA Consortia Today as never before, the old adage “there is strength in numbers” rings true. As the U.S. Environmental Protection Agency (EPA) continues to implement the amended Toxic Substances Control Act (TSCA), industry stakeholders are recognizing the immense importance of working within consortia to […]

Mar 3, 2020

FIFRA Stakeholders: How to Respond to an Enforcement Action or Inquiry – Update from Bergeson & Campbell, P.C.

In a recent Bergeson & Campbell, P.C. (B&C®) advisory memorandum, we noted that enforcement activity under the Toxic Substances Control Act (TSCA) and the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) has been increasing during the last couple of years.  That memorandum provides guidance to TSCA stakeholders on how to respond […]

Feb 28, 2020

Biobased Products News and Policy Report – Update from Bergeson & Campbell, P.C.

Biobased and Renewable Products Update February 27, 2020 Federal FDA Issues Final Rule Amending The Definition Of “Biological Product” On February 21, 2020, the U.S. Food and Drug Administration (FDA) issued a final rule to amend its regulation that defines “biological product.” The new definition incorporates changes made by the […]